{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:17:48Z","timestamp":1763036268038},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1007\/s11864-005-0012-3","type":"journal-article","created":{"date-parts":[[2007,7,4]],"date-time":"2007-07-04T17:59:47Z","timestamp":1183571987000},"page":"47-57","source":"Crossref","is-referenced-by-count":38,"title":["Overview of the management of differentiated thyroid cancer"],"prefix":"10.1007","volume":"6","author":[{"given":"Jyotika K.","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry A.","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary S.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"12_CR1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1056\/NEJM199302253280807","volume":"328","author":"EL Mazzaferri","year":"1993","unstructured":"Mazzaferri EL: Management of a solitary thyroid nodule. N Engl J Med 1993, 328:553\u2013559.","journal-title":"N Engl J Med"},{"key":"12_CR2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, et al.: Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8\u201329. Most recent data on thyroid cancer incidence,mortality. Compiled by American Cancer Society.","journal-title":"CA Cancer J Clin"},{"key":"12_CR3","doi-asserted-by":"crossref","unstructured":"Figge J JT, Gerasimov G: Thyroid cancer: a comprehensive guide to clinical mangement. Humana Press 1999, 85\u2013116.","DOI":"10.1007\/978-1-59259-199-2_8"},{"key":"12_CR4","first-page":"3563","volume":"82","author":"F Pacini","year":"1997","unstructured":"Pacini F, Vorontsova T, Demidchik EP, et al.: Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997, 82:3563\u20133569.","journal-title":"J Clin Endocrinol Metab"},{"key":"12_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1067\/msy.2000.110848","volume":"128","author":"O Alsanea","year":"2000","unstructured":"Alsanea O, Wada N, Ain K, et al.: Is familial nonmedullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 2000, 128:1043\u20131050.","journal-title":"Surgery"},{"key":"12_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","volume":"361","author":"SI Sherman","year":"2003","unstructured":"Sherman SI: Thyroid carcinoma. Lancet 2003, 361:501\u2013511. Management of thyroid cancer including differentiated,medullary and anaplastic","journal-title":"Lancet"},{"key":"12_CR7","volume-title":"Rosai and Ackerman\u2019s Surgical Pathology","author":"J Rosai","year":"2004","unstructured":"Rosai J: Rosai and Ackerman\u2019s Surgical Pathology. New York: Mosby, 2004."},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/105072502320288492","volume":"12","author":"TI Lee","year":"2002","unstructured":"Lee TI, Yang HJ, Lin SY, et al.: The accuracy of fine-needle aspiration biopsy and frozen section in patients with thyroid cancer. Thyroid 2002, 12:619\u2013626. Comparison of FNAB and FNAC in diagnosing thyroid cancer in 1076 patients.","journal-title":"Thyroid"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2265.2003.01738.x","volume":"58","author":"C Dragoiescu","year":"2003","unstructured":"Dragoiescu C, Hoekstra OS, Kuik DJ, et al.: Feasibility of a randomized trial on adjuvant radio-iodine therapy in differentiated thyroid cancer. Clin Endocrinol (Oxf) 2003, 58:451\u2013455.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"12_CR10","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.1996.00440180017002","volume":"156","author":"PA Singer","year":"1996","unstructured":"Singer PA, Cooper DS, Daniels GH, et al.: Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996, 156:2165\u20132172.","journal-title":"Arch Intern Med"},{"key":"12_CR11","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1097\/00005537-199811000-00005","volume":"108","author":"JL Netterville","year":"1998","unstructured":"Netterville JL, Coleman SC, Smith JC, et al.: Management of substernal goiter. Laryngoscope 1998, 108:1611\u20131617.","journal-title":"Laryngoscope"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00268-002-6668-y","volume":"26","author":"J Witte","year":"2002","unstructured":"Witte J, Goretzki PE, Dieken J, et al.: Importance of lymph node metastases in follicular thyroid cancer. World J Surg 2002, 26:1017\u20131022.","journal-title":"World J Surg"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1089\/105072501753211028","volume":"11","author":"PE Voutilainen","year":"2001","unstructured":"Voutilainen PE, Multanen MM, Leppaniemi AK, et al.: Prognosis after lymph node recurrence in papillary thyroid carcinoma depends on age. Thyroid 2001, 11:953\u2013957.","journal-title":"Thyroid"},{"key":"12_CR14","doi-asserted-by":"crossref","unstructured":"Freudenberg LS, Antoch G, Jentzen W, et al.: Value of (124)I-PET\/CT in staging of patients with differentiated thyroid cancer. Eur Radiol 2004. Comparison of PET \/CT scan and radioiodine whole body scan in 12 patients with thyroid cancer.","DOI":"10.1007\/s00330-004-2350-0"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02988693","volume":"14","author":"C Tiepolt","year":"2000","unstructured":"Tiepolt C, Beuthien-Baumann B, Hliscs R, et al.: 18F-FDG for the staging of patients with differentiated thyroid cancer: comparison of a dual-head coincidence gamma camera with dedicated PET. Ann Nucl Med 2000, 14:339\u2013345.","journal-title":"Ann Nucl Med"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00005537-199804000-00006","volume":"108","author":"MM Mulcahy","year":"1998","unstructured":"Mulcahy MM, Cohen JI, Anderson PE, et al.: Relative accuracy of fine-needle aspiration and frozen section in the diagnosis of well-differentiated thyroid cancer. Laryngoscope 1998, 108:494\u2013496.","journal-title":"Laryngoscope"},{"key":"12_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biopha.2003.08.025","volume":"58","author":"F Lumachi","year":"2004","unstructured":"Lumachi F, Borsato S, Tregnaghi A, et al.: Accuracy of fine-needle aspiration cytology and frozen-section examination in patients with thyroid cancer. Biomed Pharmacother 2004, 58:56\u201360.","journal-title":"Biomed Pharmacother"},{"key":"12_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4158\/EP.7.3.202","volume":"7","author":"American Association of Clinical Endocrinologists, American College of Endocrinologists, American Association of Endocrine Surgeons (AACE\/AAES)","year":"2001","unstructured":"American Association of Clinical Endocrinologists, American College of Endocrinologists, American Association of Endocrine Surgeons (AACE\/AAES): Medical\/ surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 2001, 7:202\u2013220.","journal-title":"Endocr Pract"},{"key":"12_CR19","first-page":"427","volume":"16","author":"MR Pelizzo","year":"1997","unstructured":"Pelizzo MR, Bernante P, Toniato A, Piotto A, Gemo G, Pagetta C, Bernardi C: Guidelines for the diagnosis of thyroid carcinoma. J Exp Clin Cancer Res 1997, 16:427\u2013428.","journal-title":". J Exp Clin Cancer Res"},{"key":"12_CR20","unstructured":"National Comprehensive Cancer Network (NCCN): Clinical practice guidelines in oncology: comprehensive review of thyroid cancer guidelines and literature; 2003."},{"key":"12_CR21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/105072504323150778","volume":"14","author":"A D\u2019Avanzo","year":"2004","unstructured":"D\u2019Avanzo A, Ituarte P, Treseler P, Kebebew E, Wu J, Wong M, Duh QY, Siperstein AE, Clark OH: Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 2004, 14:453\u20138.","journal-title":"Thyroid"},{"key":"12_CR22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1067\/msy.2002.122377","volume":"131","author":"AS Alzahrani","year":"2002","unstructured":"Alzahrani AS, Al Mandil M, Chaudhary MA, et al.: Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer. Surgery 2002, 131:443\u2013449. Useful guide to plan of extent of surgery in thyroid cancer patients.","journal-title":"Surgery"},{"key":"12_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9610(05)80326-5","volume":"166","author":"JP Shah","year":"1993","unstructured":"Shah JP, Loree TR, Dharker D, Strong EW: Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg 1993, 166:331\u2013335.","journal-title":"Am J Surg"},{"key":"12_CR24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jcem-56-6-1131","volume":"56","author":"NA Samaan","year":"1983","unstructured":"Samaan NA, Maheshwari YK, Nader S, et al.: Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 1983, 56:1131\u20131138.","journal-title":"J Clin Endocrinol Metab"},{"key":"12_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9610(99)00254-8","volume":"179","author":"S Beenken","year":"2000","unstructured":"Beenken S, Roye D, Weiss H, et al.: Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 2000, 179:51\u201356.","journal-title":"Am J Surg"},{"key":"12_CR26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s002680010215","volume":"24","author":"E Kebebew","year":"2000","unstructured":"Kebebew E, Duh QY, Clark OH: Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World J Surg 2000, 24:1295\u20131302.","journal-title":"World J Surg"},{"key":"12_CR27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/00005537-200207000-00013","volume":"112","author":"ME Kupferman","year":"2002","unstructured":"Kupferman ME, Mandel SJ, DiDonato L, et al.: Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer. Laryngoscope 2002, 112:1209\u20131212. Discusses safety and morbity assosciated with the surgical procedures for thyroid cancer.","journal-title":"Laryngoscope"},{"key":"12_CR28","first-page":"801","volume":"31","author":"S Nakano","year":"2004","unstructured":"Nakano S, Uenosono Y, Ehi K, et al.: Lymph nodes mapping for detection of sentinel nodes in patients with papillary thyroid cancer. Gan To Kagaku Ryoho 2004, 31:801\u2013804.","journal-title":"Gan To Kagaku Ryoho"},{"key":"12_CR29","unstructured":"Marchesi M, Biffoni M, Biancari F, Berni A, Campana FP: Predictors of outcome for patients with differentiated and aggressive thyroid carcinoma. Eur J Surg Suppl 2003:46\u201350. Identifies risk factors to guide surgeons on the extent of surgery."},{"key":"12_CR30","first-page":"333","volume":"16","author":"M Ducci","year":"1997","unstructured":"Ducci M, Appetecchia M, Marzetti M: Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma. J Exp Clin Cancer Res 1997, 16:333\u2013335.","journal-title":"J Exp Clin Cancer Res"},{"key":"12_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/1097-0142(195903\/04)12:2<371::AID-CNCR2820120221>3.0.CO;2-P","volume":"12","author":"B Catz","year":"1959","unstructured":"Catz B, Petit DW, Schwartz H, et al.: Treatment of cancer of the thyroid postoperatively with suppressive thyroid medication, radioactive iodine, and thyroid-stimulating hormone. Cancer 1959, 12:371\u2013383.","journal-title":"Cancer"},{"key":"12_CR32","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-129-8-199810150-00007","volume":"129","author":"T Taylor","year":"1998","unstructured":"Taylor T, Specker B, Robbins J, et al.: Outcome after treatment of high-risk papillary and non-Hurthle-cell follicular thyroid carcinoma. Ann Intern Med 1998, 129:622\u2013627.","journal-title":"Ann Intern Med"},{"key":"12_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1010066728437","volume":"1","author":"BR Haugen","year":"2000","unstructured":"Haugen BR: Initial treatment of differentiated thyroid carcinoma. Rev Endocr Metab Disord 2000, 1:139\u2013145.","journal-title":"Rev Endocr Metab Disord"},{"key":"12_CR34","first-page":"2541","volume":"81","author":"E Baudin","year":"1996","unstructured":"Baudin E, Schlumberger M, Lumbroso J, et al.: Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab 1996, 81:2541\u20132544.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"12_CR35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00259-002-0810-9","volume":"29","author":"M Klain","year":"2002","unstructured":"Klain M, Ricard M, Leboulleux S, et al.: Radioiodine therapy for papillary and follicular thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002, 29(Suppl 2):479\u2013485.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12_CR36","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1210\/jcem-50-4-734","volume":"50","author":"JM Goldman","year":"1980","unstructured":"Goldman JM, Line BR, Aamodt RL, Robbins J: Influence of triiodothyronine withdrawal time on 131I uptake post-thyroidectomy for thyroid cancer. J Clin Endocrinol Metab 1980, 50:734\u2013739.","journal-title":"J Clin Endocrinol Metab"},{"key":"12_CR37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.1998.8.737","volume":"8","author":"DS Cooper","year":"1998","unstructured":"Cooper DS, Specker B, Ho M, et al.: Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid 1998, 8:737\u2013744.","journal-title":"Thyroid"},{"key":"12_CR38","first-page":"4318","volume":"81","author":"P Pujol","year":"1996","unstructured":"Pujol P, Daures JP, Nsakala N, etx al.: Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996, 81:4318\u20134323.","journal-title":"J Clin Endocrinol Metab"},{"key":"12_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-113-4-265","volume":"113","author":"GM Stall","year":"1990","unstructured":"Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B: Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990, 113:265\u2013269.","journal-title":"Ann Intern Med"},{"key":"12_CR40","first-page":"4701","volume":"85","author":"B Biondi","year":"2000","unstructured":"Biondi B, Palmieri EA, Fazio S, et al.: Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000, 85:4701\u20134705.","journal-title":"J Clin Endocrinol Metab"},{"key":"12_CR41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9343(81)90573-8","volume":"70","author":"EL Mazzaferri","year":"1981","unstructured":"Mazzaferri EL, Young RL: Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 1981, 70:511\u2013518.","journal-title":"Am J Med"},{"key":"12_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V","volume":"82","author":"RW Tsang","year":"1998","unstructured":"Tsang RW, Brierley JD, Simpson WJ, et al.: The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer 1998, 82:375\u2013388. Retrospective report of the role of EBRT in differentiated thyroid cancer.","journal-title":"Cancer"},{"key":"12_CR43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0360-3016(88)90381-1","volume":"14","author":"WJ Simpson","year":"1988","unstructured":"Simpson WJ, Panzarella T, Carruthers JS, et al.: Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988, 14:1063\u20131075. Statistically improved local control demonstrated with EBRT.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12_CR44","first-page":"399","volume":"19","author":"P Philips","year":"1993","unstructured":"Philips P, Hanzen C, Andry G, et al.: Postoperative irradiation for thyroid cancer. Eur J Surg Oncol 1993, 19:399\u2013404.","journal-title":"Eur J Surg Oncol"},{"key":"12_CR45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0936-6555(03)00162-6","volume":"15","author":"D Ford","year":"2003","unstructured":"Ford D, Giridharan S, McConkey C, et al.: External beam radiotherapy in the management of differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 2003, 15:337\u2013341. Describes dose response to EBRT.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"12_CR46","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03348135","volume":"10","author":"S Ahuja","year":"1987","unstructured":"Ahuja S, Ernst H: Chemotherapy of thyroid carcinoma. J Endocrinol Invest 1987, 10:303\u2013310.","journal-title":"J Endocrinol Invest"},{"key":"12_CR47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/030089169007600513","volume":"76","author":"JP Droz","year":"1990","unstructured":"Droz JP, Schlumberger M, Rougier P, et al.: Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori 1990, 76:480\u2013483.","journal-title":"Tumori"},{"key":"12_CR48","first-page":"405","volume":"70","author":"SD Williams","year":"1986","unstructured":"Williams SD, Birch R, Einhorn LH: Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial. Cancer Treat Rep 1986, 70:405\u2013407.","journal-title":"Cancer Treat Rep"},{"key":"12_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1430015","volume":"143","author":"C Schmutzler","year":"2000","unstructured":"Schmutzler C, Koehrle J: Innovative strategies for the treatment of thyroid cancer. Eur J Endocrinol 2000, 143:15\u201324. Excellent review of emerging novel treatments for thyroid cancer.","journal-title":"Eur J Endocrinol"},{"key":"12_CR50","first-page":"1903","volume":"39","author":"F Grunwald","year":"1998","unstructured":"Grunwald F, Menzel C, Bender H, et al.: Redifferentiation therapy-induced radioiodine uptake in thyroid cancer. J Nucl Med 1998, 39:1903\u20131906.","journal-title":"J Nucl Med"},{"key":"12_CR51","first-page":"661","volume":"59","author":"RB Mandell","year":"1999","unstructured":"Mandell RB, Mandell LZ, Link CJ, Jr: Radioisotope concentrator gene therapy using the sodium\/iodide symporter gene. Cancer Res 1999, 59:661\u2013668.","journal-title":"Cancer Res"},{"key":"12_CR52","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<945::AID-CNCR24>3.0.CO;2-I","volume":"85","author":"PW Grigsby","year":"1999","unstructured":"Grigsby PW, Baglan K, Siegel BA: Surveillance of patients to detect recurrent thyroid carcinoma. Cancer 1999, 85:945\u2013951.","journal-title":"Cancer"},{"key":"12_CR53","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4158\/EP.3.3.153","volume":"3","author":"HJ Baskin","year":"1997","unstructured":"Baskin HJ: Thyroid ultrasonography: a review. Endocr Pract 1997, 3:153\u2013157. Highlights use of thyroid ultrasound in diagnosis and follow up of thyroid cancer patients.","journal-title":"Endocr Pract"},{"key":"12_CR54","first-page":"1121","volume":"83","author":"CA Spencer","year":"1998","unstructured":"Spencer CA, Takeuchi M, Kazarosyan M, et al.: Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998, 83:1121\u20131127.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0012-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11864-005-0012-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-005-0012-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:34:13Z","timestamp":1559432053000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11864-005-0012-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1007\/s11864-005-0012-3","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}